In these cold CRCs, OVs can initiate immune priming by inducing immunogenic cell death, which initiates the cancer-immunity cycle and drives dendritic cell activation and CD8+ T-cell trafficking into tumors [127]. This evidence concerns the gene CD8A and cancer.